1-8 of 8
Shelly Lensing
Close
Sort by
Journal Articles

The Dosage of Pten Is Critical in Determining the Disease Severity - a Mouse Model Differentially Mimicking JMML and CMML

Yan Yan, MD, Natalia C Colorado, MD, Shelly Lensing, MS, Delli R Robinson, Nicholas J Baltz, Daohong Zhou, MD, Peter Dean Emanuel, MD, Y. Lucy Liu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1550.
https://doi.org/10.1182/blood.V128.22.1550.1550
Published: 2016
Journal Articles

JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency

Nicholas J Baltz, Natalia C Colorado, MD, Yan Yan, MD, Shelly Lensing, MS, Delli Robinson, BA, Michele H. Cottler-Fox, MD, Jason E Farrar, MD, Peter Dean Emanuel, MD, Y. Lucy Liu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5899.
https://doi.org/10.1182/blood.V128.22.5899.5899
Published: 2016
Journal Articles

Outcome of Patients with Relapsed/Refractory AIDS-Related Lymphoma In the AIDS Malignancy Consortium (AMC) 1997–2008

Ariela Noy, MD, Ulas Darda Bayraktar, Neel Gupta, Adam M. Petrich, MD, Page Moore, Shelly Lensing for the AIDS Malignancy Consortium
Journal: Blood
Blood (2010) 116 (21): 3569.
https://doi.org/10.1182/blood.V116.21.3569.3569
Published: 2010
Journal Articles

Prophylactic Antibiotics Reduce Morbidity from Septicemia during Intensive Treatment for Pediatric Acute Myelogenous Leukemia.

Beth Kurt, MD, Patricia Flynn, MD, Jerry Shenep, MD, Raul Ribeiro, MD, Ching-Hon Pui, MD, Shelly Lensing, MS, Stanley Pounds, PhD, Bassem Razzouk, MD, Jeffrey Rubnitz, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 1919.
https://doi.org/10.1182/blood.V108.11.1919.1919
Published: 2006
Journal Articles

Outcome after Relapse of Childhood Acute Myeloid Leukemia: The St. Jude Experience.

Jeffrey Rubnitz, MD, PhD, Bassem Razzouk, MD, Shelly Lensing, MS, Stanley Pounds, PhD, Ching-Hon Pui, MD, Raul Ribeiro, MD
Journal: Blood
Blood (2005) 106 (11): 273.
https://doi.org/10.1182/blood.V106.11.273.273
Published: 2005
Journal Articles

Improved Remission Induction Rate of Childhood AML: Preliminary Results of the AML02 Trial.

Jeffrey Rubnitz, MD, PhD, Bassem Razzouk, MD, Paul Bowman, MD, Gary Dahl, MD, Norman Lacayo, MD, Jeffrey Taub, MD, Yaddanapudi Ravindranath, MD, Soheil Meshinchi, MD, PhD, Gladstone Airewele, MD, Shelly Lensing, MS, Stanley Pounds, PhD, Raul Ribeiro, MD, Ching-Hon Pui, MD, Elaine Coustan-Smith, MS, Dario Campana, MD
Journal: Blood
Blood (2005) 106 (11): 275.
https://doi.org/10.1182/blood.V106.11.275.275
Published: 2005
Journal Articles

Effect of Age on Prognosis in Childhood Acute Myeloid Leukemia.

Bassem I. Razzouk, MD, Elihu Estey, MD, Stanley B. Pounds, Ph.D, Shelly Lensing, MS, Sherry Pierce, MS, Mark Brandt, MS, Jeffrey E. Rubnitz, MD, Raul C. Ribeiro, MD, Michael Rytting, MD, Ching-Hon Pui, MD, Hagop M. Kantarjian, MD, Sima C. Jeha, MD
Journal: Blood
Blood (2004) 104 (11): 1064.
https://doi.org/10.1182/blood.V104.11.1064.1064
Published: 2004
Journal Articles

The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort

Clinical Trials & Observations
Sharon Castellino, Shelly Lensing, Caroline Riely, Shesh N. Rai, Rene Davila, Randall T. Hayden, Jackie Fleckenstein, Mark Levstik, Shari Taylor, Patrick J. Dean, Sarah Kippenbrock, Jennifer Pope, Jeanne Carr, Donald K. Strickland, Melissa M. Hudson
Journal: Blood
Blood (2004) 103 (7): 2460–2466.
https://doi.org/10.1182/blood-2003-07-2565
Published: 2004